In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1858 News Items found
Dana Pe'er
“Beautiful Patterns in Biology”: How SKI’s Dana Pe’er Earned a Top Honor and Advocates for Women Scientists

Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.
Physician-scientist Nai-Kong Cheung
Caging the Beast: MSK Researchers Design a New Radiation Treatment More Destructive to Cancer Cells

Learn about the work of Nai-Kong Cheung and other MSK scientists who have learned more about how to deliver stronger treatment with less toxicity.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at MSK
Changing the Standard of Care at MSK and Beyond: New Treatment Option for Advanced Colorectal Cancer

A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer.
Lymphoma expert Gilles Salles
Q&A
Taking on New Challenges: 8 Questions with Gilles Salles

New Lymphoma Service Chief Gilles Salles discusses his plans for research and collaborations at MSK.
Kayvan Keshari
In the Lab
Fructose Could Play a Role in Targeting Leukemia

Leukemia cells metabolize fructose in a way that could make them easier to target with drugs.
Yi-Long Wu, President of CTONG, and Sir Murray Brennan, MSK’s Senior Vice President of International Programs; center: Honorable Kevin Rudd, 26th Prime Minister of Australia and 8th President and CEO of Asia Society; right (top to bottom): Lisa DeAngelis, MSK’s Physician-in-Chief and Chief Medical Officer, and Bob Li, MSK’s Physician Ambassador to China and Asia-Pacific
In the News
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Strengthen International Collaboration During Annual Symposium

The initiative lays the groundwork for speedier cancer drug approvals in both the United States and China.
Frosty the Snowman keeps watch over Letters to Santa in MSK's Holiday Hallway.
MSK's Holiday Hallway: The Tradition Continues

For the past 27 years the MSK Facilities Team has created a beautiful holiday wonderland to spread cheer to staff and patients alike. This year, Santa’s MSK helpers came to the rescue in more ways than one.
Memorial Sloan Kettering neuro-oncologist Adrienne Boire
Roundup
Year in Review: Five Important Clinical Advances in Cancer in 2020

Read about some of the most important clinical advances made at MSK in 2020.
Dana Pe'er, Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute
Year in Review: Top 10 MSK Cancer Science Breakthroughs of 2020

Take a look back at some of the biggest cancer science stories from this past year.